About Neurolens
Neurolens is a company based in Coppell (United States) founded in 2008 by Davis Corley. Neurolens has raised $126.19 million across 9 funding rounds from investors including Marshall Wace, Trinity Cap and MVM Partners. Neurolens offers products and services including Neurolenses and Neurolens Test. Neurolens operates in a competitive market with competitors including Laclarée, Azalea Vision, SynergEyes, Nexis Vision and ABH Optics, among others.
- Headquarter Coppell, United States
- Founders Davis Corley
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$126.19 M (USD)
in 9 rounds
-
Latest Funding Round
$45 M (USD), Debt – Conventional
Dec 06, 2023
-
Investors
Marshall Wace
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neurolens
Neurolens offers a comprehensive portfolio of products and services, including Neurolenses and Neurolens Test.
Lenses that correct eye misalignment to alleviate symptoms.
Questionnaire and measurement for identifying eye misalignment.
Funding Insights of Neurolens
Neurolens has successfully raised a total of $126.19M across 9 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $45 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neurolens
Neurolens has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Marshall Wace, Trinity Cap and MVM Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt and equipment financing are provided to growth-stage companies.
|
Locked | Locked | Locked | |
|
Private equity investments in healthcare companies are managed.
|
Locked | Locked | Locked | |
|
Long-short equity strategies are managed through specialized hedge funds.
|
Locked | Locked | Locked |
Investor details for Neurolens
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neurolens
Investment portfolio details for Neurolens
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neurolens
Detailed financials for Neurolens
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurolens Comparisons
Peer comparison for Neurolens
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neurolens
Neurolens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laclarée, Azalea Vision, SynergEyes, Nexis Vision and ABH Optics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Eye-wear solutions for presbyopia correction are developed using liquid refraction.
|
|
| Locked | Locked | Locked |
Developer of technology for people with high light sensitivity and ocular disorders
|
|
| Locked | Locked | Locked |
Hybrid contact lense manufacturers
|
|
| Locked | Locked | Locked |
Ocular lens and surface technologies for ophthalmic devices are developed.
|
|
| Locked | Locked | Locked |
Developer of lightweight eyeglass lenses
|
Detailed competitors of Neurolens
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurolens
Complete news archive for Neurolens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurolens
Neurolens was founded in 2008 and raised its 1st funding round 6 years after it was founded.
Neurolens is headquartered in Coppell, United States. It is registered at Coppell, Texas, United States.
Davis Corley is the current CEO of Neurolens. They have also founded this company.
Neurolens is a funded company, having raised a total of $126.19M across 9 funding rounds to date.
Provider of prescription lenses and solution for problems related to Digital Vision Syndrome. The company has a patented Contoured Prism technology and is the first and only prescription lenses to provide comfort for the majority of adults who complain of headaches, neckshoulder pain, and eyestrain when using digital devices, reading, or doing detail work, the daily symptoms of Digital Vision Syndrome, DVS. With this technology, the company corrects eye misalignment naturally and provides comfortable vision.
Neurolens's top competitors include Azalea Vision, Laclarée and SynergEyes.
Neurolens offers Neurolenses and Neurolens Test.
Neurolens has 5 investors. Key investors include Marshall Wace, Trinity Cap, MVM Partners, Falcon-Vision, and Bluestem.